Last reviewed · How we verify
Lactobacillus salivarius PS2 — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Lactobacillus salivarius PS2 (Lactobacillus salivarius PS2) — Universidad Complutense de Madrid.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Lactobacillus salivarius PS2 TARGET | Lactobacillus salivarius PS2 | Universidad Complutense de Madrid | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Lactobacillus salivarius PS2 CI watch — RSS
- Lactobacillus salivarius PS2 CI watch — Atom
- Lactobacillus salivarius PS2 CI watch — JSON
- Lactobacillus salivarius PS2 alone — RSS
Cite this brief
Drug Landscape (2026). Lactobacillus salivarius PS2 — Competitive Intelligence Brief. https://druglandscape.com/ci/lactobacillus-salivarius-ps2. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing